Inspire Advisors’s Avanos Medical AVNS Stock Holding History

Inspire Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-29	Closed	-$1K	–	136
2020 Q4	$1K	Buy	+29	New	+$1.21K	﹤0.01%	715

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Inspire Advisors's AVNS Position: Q1 2021 in Review

Inspire Advisors sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 29 shares — an estimated $1K sold.

Inspire Advisors first reported a position in AVNS in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

Inspire Advisors reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 29 Avanos Medical shares in Q1 2021, an estimated $1K.
Inspire Advisors first reported a position in Avanos Medical in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Avanos Medical position peaked at $1K in Q4 2020.
291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.